Skip to content
Nonprofiteer
← AMARANTH DIABETES FOUNDATION INC

Form 990 for tax year 2024

Filed by AMARANTH DIABETES FOUNDATION INC.

Totals

Total revenue
$517,143
Total expenses
$525,843
Contributions and grants received
$516,863
Grants paid
$509,066
Program service revenue
$0
Investment income
$280
Other revenue
$0
Total assets, end of year
$791,973
Total liabilities, end of year
$0
Net assets or fund balances, end of year
$791,973
Program services expenses (Part IX)
$509,066
Management and general expenses
$16,777
Fundraising expenses
$0
Program service expenses (Part III)
$509,066

Program services were 96.8% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1f · All other contributions, gifts and grants

    $516,863

  • 3 · Investment income

    total $280 · related or exempt $280

  • 8c · Net income from fundraising events

    total $0

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $509,066 · program services $509,066

  • 13 · Office expenses

    total $16,777 · management and general $16,777

Balance sheet

Part X, book values.

  • 2 · Savings and temporary cash investments

    beginning of year $800,673 · end of year $791,973

  • 27 · Net assets without donor restrictions

    beginning of year $698,633 · end of year $689,933

  • 28 · Net assets with donor restrictions

    beginning of year $102,040 · end of year $102,040

Mission and programs · 2024

Mission

TO MAKE ANNUAL DONATION TO THE AMERICAN DIABETES RESEARCH FOUNDATION

  • TO MAKE AN ANNUAL DONATION TO THE AMERICAN DIABETES RESEARCH FOUNDATION

    Expenses $509,066

As filed on the 2024 return.

Listed in Part VII

  • GWEN ROCHETTE

    DIRECTOR

    Total calculated
    $0
    Hours/week
    5
  • DOUGLAS REECE

    DIRECTOR

    Total calculated
    $0
    Hours/week
    5
  • MARSHA WEIDINGER

    SUPREME ASSOCIATE MATRON

    Total calculated
    $0
    Hours/week
    5
  • WILLIAM HAAS

    SUPREME ASSOCIATE PATRON

    Total calculated
    $0
    Hours/week
    5
  • RICHARD MARSH

    SUPREME ROYAL PATRON

    Total calculated
    $0
    Hours/week
    5
  • SUSAN MCKINNEY

    DIRECTOR

    Total calculated
    $0
    Hours/week
    5
  • DEE BARGER

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • ELIZABETH HERBOLSHEIMER

    SUPREME ROYAL MATRON

    Total calculated
    $0
    Hours/week
    5
  • HOLLY STIVERS

    SUPREME ASSOCIATE CONDUCTRESS

    Total calculated
    $0
    Hours/week
    5
  • EMILY S MOYER

    SUPREME CONDUCTRESS

    Total calculated
    $0
    Hours/week
    5
  • CHARLENE TUCKER

    PRESIDENT

    Total calculated
    $0
    Hours/week
    5
  • HILLARY JOHNSON

    TREASURER

    Total calculated
    $0
    Hours/week
    5
  • MIRANDA PERUSO

    VICE PRESIDENT

    Total calculated
    $0
    Hours/week
    5
  • TIFFANY ST JOHN

    SECRETARY

    Total calculated
    $0
    Hours/week
    5

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.

Grants on this return

Provenance

Return type
form_990
Tax year
2024
Filed
30 June 2025
IRS schema version
2024v5.2
Source object
202512119349300621

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.